Open Actively Recruiting

A long-term study to further evaluate the risk of hepatotoxicity associated with TURALIO™ (pexidartinib) treatment

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
Phase IV

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
21-000498
Category
Kidney Cancer
Location
  • UCLA Santa Monica
  • UCLA Westwood